Adults considering one-time ROCTAVIAN™ (valoctocogene roxaparvovecrvox) gene therapy can rely on a BioMarin experienced resource throughout their treatment journey
Important Warning: PALYNZIQ can cause a severe allergic reaction (anaphylaxis) that may be life threatening and can happen any time during treatment with PALYNZIQ.
BioMarin RareConnections™ is there from the start with:
- Personalized support—individualized, one-to-one assistance and education to start and continue the ROCTAVIAN journey—from pre-infusion eligibility testing to the one-time infusion, to post-infusion monitoring
- Financial navigation support
- Understanding your potential out-of-pocket costs associated with one-time ROCTAVIAN gene therapy
- Navigating the insurance process and understanding coverage options to gain access to gene therapy treatment
- Identifying financial assistance options patients may be eligible for, such as co-pay assistance* for ROCTAVIAN gene therapy treatment, pre-infusion laboratory services, and post-infusion follow-up services for qualified commercially insured patients
- Educating the doctor’s office on insurance coverage requirements for access to gene therapy treatment
Navigating Prescription Drug Insurance GuideA comprehensive guide to help you advocate for drug coverage.
VOXZOGO Patient Support ProgramBioMarin offers a comprehensive Patient Support Program to assist VOXZOGO patients and their families.
To enroll in BioMarin RareConnections and get connected with your Case Manager, start by completing the Patient Consent Form (PCF)
You must complete the VOXZOGO PCF in order to receive support from BioMarin RareConnections.
To enroll in BioMarin RareConnections and connect with a team member, start by completing the Patient Consent Form (PCF)
You must complete the ROCTAVIAN PCF to receive support from BioMarin RareConnections.
*Valid only for those patients with commercial prescription insurance coverage for products who meet eligibility criteria. Offer not valid for prescriptions, administration, or related labs reimbursed, in whole or in part, by any federal, state, or government-funded insurance programs (for example, Medicare, Medicare Advantage, Medigap, Medicaid, VA, DoD, or TRICARE), for cash-paying patients, where product, administration, or related lab, are not covered by patient’s commercial insurance, where patient’s commercial insurance plan reimburses them for the entire cost of their prescription drug, administration, and/or related labs, or where prohibited by law or by the patient’s health insurance provider. Patients who are residents of certain states (MA or RI) are not eligible for drug administration co-pay support. Patients who are residents of certain states (MI, MN, or RI) are not eligible for laboratory services co-pay support. If at any time a patient begins receiving prescription drug, administration, or related lab coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the BioMarin Co-Pay Assistance Program and patient must notify BioMarin RareConnections™ at 1-833-ROCTAVIAN (1-833-762-8284) to stop participation. Patients may not seek reimbursement for the value of the out-of-pocket expense amount covered by the Program from any third-party payer, whether public or private. The Program is valid ONLY for qualifying patients residing in the 50 U.S. states or in Puerto Rico with commercial insurance who have a valid prescription for an FDA-approved indication for the qualifying BioMarin therapy. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. Co-payment assistance under the Program is not transferable. BioMarin Pharmaceutical Inc. reserves the right to rescind, revoke, or amend the Program without notice. Patient/caregiver certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. The Program is subject to termination or modification at any time. Some restrictions apply.